Trials / Unknown
UnknownNCT02036112
Conventional Versus Individual Extralvator Abdominoperineal Excision for Advanced Lower Rectal Cancer
Randomized Clinical Trial of Conventional Versus Individual Extralevator Abdominoperineal Excision for Locally Advanced Lower Rectal Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Beijing Chao Yang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
An alternative treatment for low rectal cancer is the extralevator abdominoperineal excision (ELAPE) technique. We aim to compare the outcomes of patients undergoing conventional ELAPE versus Individual ELAPE.
Detailed description
We suppose that the ELAPE technique may be performed according to individual conditions. For the rectal tumors suitable for ELAPE, most of them were circular or nearly circular infiltrating tumors. Patients with these rectal tumors should receive full ELAPE resection. In those rectal tumors not involving the levator ani muscle, the dissection plane may continue close to the external anal sphincter and the levator ani muscle, leaving the ischioanal fat and the terminal branches of the pudendal nerve intact.If the tumor has only penetrated into 1 side of the levator ani muscle, the dissection might include the levator ani muscle and the fat of the ischioanal fossa on the side of the tumor to achieve a clear circumferential resection margin, whereas the ischioanal fat and levator ani muscle on the other side of the tumor may be left . This individual ELAPE may be as effective as conventional ELAPE while minimizing the operative trauma and the damage to the nerves of the genital organs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | conventional ELAPE | device |
| PROCEDURE | Individual ELAPE | device |
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2016-08-01
- Completion
- 2016-08-01
- First posted
- 2014-01-14
- Last updated
- 2014-01-14
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02036112. Inclusion in this directory is not an endorsement.